Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Research
Clinical trials
Clinical trials saw the birth and period of the names that
ranges from Egyptian Imhotep to James Lind. As the scientific
advances continue to occur, there will be new ethical and
regulatory challenges requiring dynamic updates in ethical
and legal framework of clinical trials.
This article highlights the major milestones in the evolution of
clinical trials.
1923
Randomization or blind clinical trials were introduced. This involves giving random treatments to participants
one being a placebo and the other a new drug. Its called blind trial because neither group knew which
treatment received.
1944
This period saw the introduction of multi-center clinical trials where multiple studies are conducted at various
sites; but all use the same protocol to get wider testing and better statistical data.
Evolution of ethical and regulatory frameworks
1947
The Nuremberg Code was developed that outlines 10 basic statements for the safety of human participants
in clinical trials.
1964
The Declaration of Helsinki was developed that outlines ethical codes for physicians and safety of
participants in clinical trials worldwide.
1988
The U.S. FDA was given more authority and accountability over the approval of novel drugs and treatments.
1990
Assembly of the International Conference on Harmonization (ICH) to provide help and eliminate differences
in drug development requirements for three global pharmaceutical markets: U.S. and The EU, Japan. The
ICH initiates promoting increased efficiency in the development of novel drugs and making them more
available to patients and the public.
2000
A Common Technical Document (CTD) was developed. The CTD acts as a standard casebook used in
Europe, Japan and the U.S. for proposing data gathered in clinical trials to respective governing authorities.
Thank You